We ve got a very long history of working with Amersham Pharmacia Biotech. It s over 15 years, and we supply them with products for them to distribute worldwide, primarily aimed for the DNA and protein analysis markets. That s the first part of that proteomics business. The second part is we ve acquired and licensed a group of technologies around the rapid purification of very small protein and DNA samples. This is really what people talk about when they talk about proteomics.
Proteomics is really just high throughput protein biology.
People used to call this stuff biology, and now they call it proteomics. We had genomics before that, and that was also called biology before people called it genomics. And really, the difference between biology and proteomics and genomics is simply throughput. People are sort of industrializing the approach to genomics, which has really pretty much been done now. Most of the breakthroughs there have been done with the sequencing of the human genome, and the market is starting to focus more on proteomics, or the understanding of proteins.